AMBROXOL EG LABO CONSEIL 30 mg, scored tablet 30 tablets
Active ingredients: Ambroxol hydrochloride
Commercialized according to BDPM
Scored tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMBROXOL EG LABO CONSEIL 30 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium PVDC de 30 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2000
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61243903CIP73488686CIP133400934886867Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AMBROXOLcomprimé | 30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.